HRT

From the FDA website:
The Food and Drug Administration has received requests from the public to provide updated product information for estrogen- and progestin-containing drug products used for treating postmenopausal symptoms. Information from the Womens Health Initiative (WHI) trial about estrogens and progestin continues to have significant public health implications for postmenopausal women. As the series of new study results from the WHI become available, we are encouraging manufacturers to update their labels for estrogen- and progestin-containing drug products for postmenopausal women to include new information from these studies. This information will allow individuals to understand the risks and benefits of these products and make appropriate health care decisions. This web page lists products with approved updated labeling that includes the important information from the WHI studies.

Uses
HRT is medication containing one or more female hormones, commonly estrogen plus progestin (synthetic progesterone). Some women receive estrogen-only therapy (usually women who have had their uterus removed).

• Early end for HRT clinical trial